Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of HUTCHMED (China) (NASDAQ:HCM) through any online brokerage.
Other companies in HUTCHMED (China)’s space includes: Atai Beckley NV (NASDAQ:ATAI), WAVE Life Sciences Ltd (NASDAQ:WVE), Supernus Pharmaceuticals Inc (NASDAQ:SUPN), Tarsus Pharmaceuticals Inc (NASDAQ:TARS) and Phibro Animal Health Corp (NASDAQ:PAHC).
HUTCHMED (China) has a consensus price target of $26.57.
The stock price for HUTCHMED (China) (NASDAQ: HCM) is $13.6 last updated December 11, 2025 at 4:02 PM EST.
There are no upcoming dividends for HUTCHMED (China).
HUTCHMED (China) does not have any upcoming earnings scheduled.
There is no upcoming split for HUTCHMED (China).
HUTCHMED (China) is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.